Heme: modulator of plasma systems in hemolytic diseases

LT Roumenina, J Rayes, S Lacroix-Desmazes… - Trends in molecular …, 2016 - cell.com
LT Roumenina, J Rayes, S Lacroix-Desmazes, JD Dimitrov
Trends in molecular medicine, 2016cell.com
Hemolytic diseases such as sickle-cell disease, β-thalassemia, malaria, and autoimmune
hemolytic anemia continue to present serious clinical hurdles. In these diseases, lysis of
erythrocytes causes the release of hemoglobin and heme into plasma. Extracellular heme
has strong proinflammatory potential and activates immune cells and endothelium, thus
contributing to disease pathogenesis. Recent studies have revealed that heme can interfere
with the function of plasma effector systems such as the coagulation and complement …
Hemolytic diseases such as sickle-cell disease, β-thalassemia, malaria, and autoimmune hemolytic anemia continue to present serious clinical hurdles. In these diseases, lysis of erythrocytes causes the release of hemoglobin and heme into plasma. Extracellular heme has strong proinflammatory potential and activates immune cells and endothelium, thus contributing to disease pathogenesis. Recent studies have revealed that heme can interfere with the function of plasma effector systems such as the coagulation and complement cascades, in addition to the activity of immunoglobulins. Any perturbation in such functions may have severe pathological consequences. In this review we analyze heme interactions with coagulation, complement, and immunoglobulins. Deciphering such interactions to better understand the complex pathogenesis of hemolytic diseases is pivotal.
cell.com